Sorry if my post seemed to be critical of your view newB. I...

Sorry if my post seemed to be critical of your view newB. I meant to imply that I am always negative to your positive. For each positive buyer there must be a negative seller so there are always two different views.

For the record, whilst I was positive about SIP when the shares were 30c each, I sold out at 62 and wouldn't go near them now for the same reasons as my negativities about API.

Pharmacy wholesalers are in a cut throat business with tiny margins and pressure coming to reduce margin.

The major positive I see going forwards is that there are 3 major players and they are all must be in a similar position as to cost of doing business and gross and net margins, which in my opinion only, is unsustainable.

Eventually, they must all reduce trading terms for customers and generate more profit to get a healthier bottom line. In that scenario then both stocks should soar. (Unfortunately, that means I will make less profit in my business.)

The second I get an inkling of that happening, I will be jumping back into both stocks.

In which case, I hope there are some negative people holding shares when I turn optimistic.

But when I reflect on your post and the earning per share and the dividend yield, it does make a lot of sense to the argument that the share is undervalued. However, I will wait for a scenario where profitability returns.

There is talk growing that Pfizer may be forced back, which would add turnover and restore net margin due to economies of scale. If the wholesalers can resist the temptation to try to compete robustly, then all should be good if that happened.